2AI Samaraee A, McCallum IJ, Mudawi A. Endovenous therapy of varicose veins: a better outcome than standard surgery? [J]. Surgeon, 2009, 7(3): 181-186.
4Rabe E, Otto J, Schliephak D, et al. Efficacy and safety of great saphenous vein sclerotherapy using standardised polidocanol foam (ESAF) : a randomised controlled multicentre clinical trial [ J ]. Eur J Vasc Endovasc Surg, 2008, 35(2): 238-245.
5Ouvry P, Allaert FA, Desnos P, et al. Efficacy of polidocanol foam versus liquid in sclerotherapy of the great saphenous vein: a muhicentre randomised controlled trial with a 2-year follow-up [ J ]. Eur J Vasc Endovasc Surg, 2008, 36(3) : 366-370.
6Levy JL, Trelles MA, Levy A, et al. Photography in dermatology: comparison between slides and digital imaging[J]. J Cosmet Dermatol, 2003, 2 (3-4) : 131- 134.
7Blaise S, Bosson JL, Diamand JM. Ultrasound-guided sclerotherapy of the great saphenous vein with 1% vs. 3% polidocanol foam: a multicentre double-blind randomised trial with 3-year follow-up [ J ]. Eur J Vasc Endovasc Surg, 2010, 39(6) : 779-786.
9Goldman PM. Polidocanol (aethoxysklerol) for sclerotherapy of superficial venules and telangiectasias [ J ]. J Dermatol Surg Oncol, 1989, 15(2) :204-209.
10Norris M J, Carlin MC, Ratz JL. Treatment of essential telangiectasia: effects of increasing concentrations of polidocanol[J]. J Am Acad Dermatol, 1989, 20(4) : 643-649.
